Rileptid

Medicinal product

(Invented) name

Rileptid

Active substance (s)

Risperidonas

Strength

4 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AX08, Risperidone

Marketing authorisation holder

EGIS Pharmaceuticals PLC, Vengrija

Date of authorisation

2006-09-18

Date of renewal

2011-01-26

Documents

0557_1_12 Rileptid PCS PL 191216.docx

0557_1_12 Pakuotės lapelis 191216.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

HU/H/0119/004/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Risperidonas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
18914	22419	1022419	lizdinė plokštelė	N10		Receptinis	LT/1/06/0557/010	Netiekiama	-	-	No	-	-
20362	4679	1004679	lizdinė plokštelė	N20		Receptinis	LT/1/06/0557/011	Netiekiama	-	-	No	-	-	Download
20363	23378	1023378	lizdinė plokštelė	N60		Receptinis	LT/1/06/0557/012	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-15	Išregistruotas
2011-01-26	Perregistruotas
2006-09-18	Registruotas